New drug added to cancer treatment combo in hopes of boosting immune attack
Disease control
Terminated
This study tested whether adding an experimental drug called IMSA101 to a standard cancer treatment combination was safe and more effective. The combination included precise radiation therapy and immunotherapy drugs. The trial was for adults with a limited number of cancer metast…
Phase: PHASE2 • Sponsor: ImmuneSensor Therapeutics Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC